Civic Intelligence

Melanoma Research Foundation

990 • Fiscal year 2020 • EIN 80-0671049

Apr 01, 2019 to Mar 31, 2020 • Filed on Oct 16, 2020

Organization ProfileWWW.MELANOMA.ORG/RESEARCH/MRF-BREAKTHROUGH-CONSOR
1420 K Street NW 7th FloorWashington, DC 20005

(202) 347-9675

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

65th percentile

0.15x

Higher debt load relative to assets than 65% of similar nonprofits.

2020 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2020

Liabilities / Revenue

71st percentile

0.21x

Higher debt load relative to revenue than 71% of similar nonprofits.

2020 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2020

Net Margin

43rd percentile

2.8%

Higher net margin than 43% of similar nonprofits.

2020 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2020

Top Officer Pay

51st percentile

$0

Higher top officer pay than 51% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2020 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2020

Asset Growth

15th percentile

-7.5%

Faster asset growth than 15% of similar nonprofits.

2020 filings • 501(c)3 • $500k-$1M nonprofits • Annualized from 2019 to 2020

Revenue Growth

58th percentile

4.1%

Faster revenue growth than 58% of similar nonprofits.

2020 filings • 501(c)3 • $500k-$1M nonprofits • Annualized from 2019 to 2020

Balance Sheet
Liabilities / Assets65th percentile

Assets

Down

$558,333

Down $45,511 (-7.5%) from 2019

Net Assets

Up

$474,750

Up $10,991 (+2.4%) from 2019

Liabilities

Down

$83,583

Down $56,502 (-40%) from 2019

Revenue And Expenses
Liabilities / Revenue71st percentileNet Margin43rd percentile

Revenue

Up

$390,534

Up $15,257 (+4.1%) from 2019

Expenses

Up

$379,543

Up $288,488 (+317%) from 2019

Net Income

Down

$10,991

Down $273,231 (-96%) from 2019

Historical Trend

Balance Sheet Trend

Asset Growth15th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$1.5M$1.0M$500K$0Assets 2014: $1,186,063Liabilities 2014: $1,128,281Net Assets 2014: $57,7822014Assets 2015: $1,251,181Liabilities 2015: $1,199,631Net Assets 2015: $51,5502015Assets 2016: $987,202Liabilities 2016: $732,432Net Assets 2016: $254,7702016Assets 2017: $305,214Liabilities 2017: $69,332Net Assets 2017: $235,8822017Assets 2018: $585,783Liabilities 2018: $406,246Net Assets 2018: $179,5372018Assets 2019: $603,844Liabilities 2019: $140,085Net Assets 2019: $463,7592019Assets 2020: $558,333Liabilities 2020: $83,583Net Assets 2020: $474,7502020Assets 2021: $0Liabilities 2021: $0Net Assets 2021: $02021

Highlighted filing

2020

Assets$558,333
Liabilities$83,583
Net Assets$474,750
Open 2020 Filing

Operations Trend

Revenue Growth58th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.0M$500K$0-$500KRevenue 2014: $854,480Expenses 2014: $957,136Net Income 2014: -$102,6562014Revenue 2015: $135,460Expenses 2015: $164,231Net Income 2015: -$28,7712015Revenue 2016: $708,867Expenses 2016: $543,146Net Income 2016: $165,7212016Revenue 2017: $224,006Expenses 2017: $242,894Net Income 2017: -$18,8882017Revenue 2018: $544,135Expenses 2018: $600,480Net Income 2018: -$56,3452018Revenue 2019: $375,277Expenses 2019: $91,055Net Income 2019: $284,2222019Revenue 2020: $390,534Expenses 2020: $379,543Net Income 2020: $10,9912020Revenue 2021: $320,000Expenses 2021: $314,821Net Income 2021: $5,1792021

Highlighted filing

2020

Revenue$390,534
Expenses$379,543
Net Income$10,991
Open 2020 Filing
Jump To
Filing Snapshot
Filing Period
Apr 1, 2019 to Mar 31, 2020
Signed
Oct 16, 2020
Return Version
2019v5.1
Gross Receipts
$390,534
Mission and Program Overview

Mission

The mission of the melanoma research foundation breakthrough consortium, inc. (the consortium) is to accelerate the research and development of the most promising therapeutics in melanoma in order to deliver curative options to patients. The consortium will develop collaborative, multi-sector partnerships across the breadth of melanoma disciplines - basic, translational and clinical science - to expedite development of combinations of therapies as well as novel single agents; support pre-clinical research to facilitate rational combinations; create a virtual annotated specimen biorepository; and identify biomarkers that have prognostic and predictive value or value as a new therapeutic target.

Supports clinical trials, drug develop. & research relating to treatment & prevention of melanoma.

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$400,071$508,321▲ $108,250
Prepaid Expenses and Deferred Charges$4,974$29,478▲ $24,504
Total Assets$603,844$558,333▼ $45,511
Other Assets Total$198,799$20,534▼ $178,265
Liabilities
Grants Payable$128,137$75,000▼ $53,137
Accounts Payable and Accrued Expenses$11,948$8,583▼ $3,365
Total Liabilities$140,085$83,583▼ $56,502
Net Assets / Fund Balance
Net Assets With Donor Restrictions$376,658$400,150▲ $23,492
Net Assets Without Donor Restrictions$87,101$74,600▼ $12,501
Total Net Assets Fund Balance$463,759$474,750▲ $10,991
Total Liabilities and Net Assets / Fund Balance$603,844$558,333▼ $45,511
Compensation and Service Providers
Top Officer Pay51st percentile

Board Members and Trustees

NameTitle
Steve SilversteinChairman & President
Lynn Schuchter Md ExecutiveVice President - Until 09/2019
Alison MartinBoard Member
Jeffrey E Gershenwald MdBoard Member
Keith T Flaherty MdBoard Member
Michael B Atkins MdBoard Member
ZE'EV RONAI PHDBoard Member
Meenhard Herlyn Dvm DscSecretary - Until 09/2019
Anthony T HendricksonTreasurer & CFO
Revenue and Support

Revenue Composition

Contributions and Grants
$390,534
Program Service Revenue
$0
Investment Income
$0
Other Revenue
$0
All Other Contributions
$370,000
Change in Net Assets
$10,991
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$300,000
Other Expenses$79,543
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$300,000--$300,000
Fees for Services Other$18,244--$18,244
Insurance-$10,176-$10,176
Fees for Services Accounting-$2,390-$2,390
Other Expenses$47,761$472-$472
Total Functional Expenses$366,005$13,538$0$379,543
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
University of PittsburghPittsburgh, PA501(c)(3)Research$300,000
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
Yes
Key decisions subject to board approval
Yes
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section A, Line 6

“The consortium has one class of members. The qualifications and eligibility for membership and the manner of admission into membership shall be prescribed by resolution of the board of directors and/or by any similarly prescribed rules and regulations which the board of directors may promulgate.”

Form 990, Part VI, Section A, Line 7A

“Each membership shall entitle the holder thereof to one vote in all matters which are required or permitted to be submitted to the membership, including the election or appointment of the board of directors of the consortium.”

Form 990, Part VI, Section A, Line 7B

“Each membership shall entitle the holder thereof to one vote in all matters which are required or permitted to be submitted to the membership, including the election or appointment of the board of directors of the consortium.”

Form 990, Part VI, Section B, Line 11B

“The consortium hires an independent accounting firm to prepare the federal form 990. Upon submission of the final draft 990, the board of directors reviews and approves prior to filing with the internal revenue service.”

Form 990, Part VI, Section B, Line 12C

“Full disclosure, by notice in writing, shall be made by the interested parties to the full board of directors with respect to all conflicts of interest. Following full disclosure of a potential conflict, the board of directors will determine if a conflict exists. Should a conflict exist, that interested person will not participate in any discussion or vote on the matter.”

Form 990, Part VI, Section C, Line 19

“The governing documents, conflicts of interest policy, and financial statements are available to the public upon request.”

Filing and Contact Details

Filer

Filer Name
Melanoma Research Foundation
EIN
80-0671049
Phone
2023479675
Address
1420 K STREET NW 7TH FLOOR, WASHINGTON, DC 20005

Signing Officer

Name
Anthony T Hendrickson
Title
Treasurer & CFO
Phone
2023479675
Signed
2020-10-16
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Anthony T Hendrickson
Formed
2010
Legal Domicile
Dc
Voting Board Members
7
Independent Board Members
7
Employees
0
Volunteers
9

Preparer

Firm
Marcum Llp
Address
1899 L STREET NW SUITE 850, WASHINGTON, DC 20036
Preparer
Frank H Smith
Phone
2022274000
Supplemental Narrative

Financial Statement Notes

PART X, LINE 2:

“The consortium performed an evaluation of uncertainty in income taxes for the year ended march 31, 2020, and determined that there were no matters that would require recognition in the financial statements or that may have any effect on its tax-exempt status.”

Raw XML AppendixShowing 400 of 425 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt011948
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt08583
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0SUPPORTS CLINICAL TRIALS, DRUG DEVELOP. & RESEARCH RELATING TO TREATMENT & PREVENTION OF MELANOMA.
IRS990/AllOtherContributionsAmt0370000
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0ANTHONY T HENDRICKSON
IRS990/BooksInCareOfDetail/PhoneNum02023479675
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt01420 K STREET NW 7TH FLOOR
IRS990/BooksInCareOfDetail/USAddress/CityNm0WASHINGTON
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0DC
IRS990/BooksInCareOfDetail/USAddress/ZIPCd020005
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt0400071
IRS990/CashNonInterestBearingGrp/EOYAmt0508321
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd01
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt0390534
IRS990/CYGrantsAndSimilarPaidAmt0300000
IRS990/CYInvestmentIncomeAmt00
IRS990/CYOtherExpensesAmt079543
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt010991
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt0379543
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0390534
IRS990/DecisionsSubjectToApprovaInd01
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/Desc0THE CONSORTIUM SEEKS TO ACCELERATE RESEARCH AND DEVELOPMENT OF THE MOST PROMISING THERAPEUTICS IN MELANOMA IN ORDER TO DELIVER CURATIVE OPTIONS TO PATIENTS. SUCCESS IN THIS ENDEAVOR ALSO FURTHERS THE EXEMPT PURPOSE OF THE MELANOMA RESEARCH FOUNDATION (MRF). IN ORDER TO ACHIEVE ITS MISSION, THE CONSORTIUM WILL DEVELOP COLLABORATIVE, MULTI-SECTOR PARTNERSHIPS ACROSS THE BREADTH OF MELANOMA DISCIPLINES- BASIC, TRANSLATIONAL AND CLINICAL SCIENCE- TO EXPEDITE DEVELOPMENT OF COMBINATION THERAPIES AS WELL AS NOVEL SINGLE AGENTS; SUPPORT PRECLINICAL RESEARCH TO FACILITATE RATIONAL COMBINATIONS; CREATE A VIRTUAL ANNOTATED SPECIMEN BIOREPOSITORY; AND IDENTIFY BIOMARKERS THAT HAVE PROGNOSTIC AND PREDICTIVE VALUE OR VALUE AS NEW THERAPEUTIC TARGETS WHICH REQUIRED THE EXPERTISE OF A MD AND PROJECT MANAGER. IN ADDITION, THE CONSORTIUM'S BOARD OF DIRECTORS AND PARTICIPATING RESEARCH INSTITUTIONS WILL CONDUCT OUTREACH TO MULTI SECTOR PARTNERS WITH AN INTEREST OR INVESTMENT IN MELANOMA RESEARCH TO ENSURE THAT THE CONSORTIUM IS AWARE OF ANY IMPORTANT DEVELOPMENTS OR PROMISING RESEARCH IN THE FIELD OF MELANOMA.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt0376658
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt0400150
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd01
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt0366005
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt02390
IRS990/FeesForServicesAccountingGrp/TotalAmt02390
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt018244
IRS990/FeesForServicesOtherGrp/TotalAmt018244
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt02.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt01.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt71.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt81.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/PersonNm0STEVE SILVERSTEIN
IRS990/Form990PartVIISectionAGrp/PersonNm1LYNN SCHUCHTER MD EXECUTIVE
IRS990/Form990PartVIISectionAGrp/PersonNm2MEENHARD HERLYN DVM DSC
IRS990/Form990PartVIISectionAGrp/PersonNm3ANTHONY T HENDRICKSON
IRS990/Form990PartVIISectionAGrp/PersonNm4MICHAEL B ATKINS MD
IRS990/Form990PartVIISectionAGrp/PersonNm5KEITH T FLAHERTY MD
IRS990/Form990PartVIISectionAGrp/PersonNm6JEFFREY E GERSHENWALD MD
IRS990/Form990PartVIISectionAGrp/PersonNm7ALISON MARTIN
IRS990/Form990PartVIISectionAGrp/PersonNm8ZE'EV RONAI PHD
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/TitleTxt0CHAIRMAN & PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1VICE PRESIDENT - UNTIL 09/2019
IRS990/Form990PartVIISectionAGrp/TitleTxt2SECRETARY - UNTIL 09/2019
IRS990/Form990PartVIISectionAGrp/TitleTxt3TREASURER & CFO
IRS990/Form990PartVIISectionAGrp/TitleTxt4BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt5BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt6BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt7BOARD MEMBER
IRS990/Form990PartVIISectionAGrp/TitleTxt8BOARD MEMBER
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02010
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/ConsolidatedBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt07
IRS990/GrantAmt0300000
IRS990/GrantsPayableGrp/BOYAmt0128137
IRS990/GrantsPayableGrp/EOYAmt075000
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt0300000
IRS990/GrantsToDomesticOrgsGrp/TotalAmt0300000
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt0390534
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd01
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt07
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InsuranceGrp/ManagementAndGeneralAmt010176
IRS990/InsuranceGrp/TotalAmt010176
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt01
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0DC
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd01
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0THE MISSION OF THE MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM, INC. (THE CONSORTIUM) IS TO ACCELERATE THE RESEARCH AND DEVELOPMENT OF THE MOST PROMISING THERAPEUTICS IN MELANOMA IN ORDER TO DELIVER CURATIVE OPTIONS TO PATIENTS. THE CONSORTIUM WILL DEVELOP COLLABORATIVE, MULTI-SECTOR PARTNERSHIPS ACROSS THE BREADTH OF MELANOMA DISCIPLINES - BASIC, TRANSLATIONAL AND CLINICAL SCIENCE - TO EXPEDITE DEVELOPMENT OF COMBINATIONS OF THERAPIES AS WELL AS NOVEL SINGLE AGENTS; SUPPORT PRE-CLINICAL RESEARCH TO FACILITATE RATIONAL COMBINATIONS; CREATE A VIRTUAL ANNOTATED SPECIMEN BIOREPOSITORY; AND IDENTIFY BIOMARKERS THAT HAVE PROGNOSTIC AND PREDICTIVE VALUE OR VALUE AS A NEW THERAPEUTIC TARGET.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt0463759
IRS990/NetAssetsOrFundBalancesEOYAmt0474750
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt087101
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt074600
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd00
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt0198799
IRS990/OtherAssetsTotalGrp/EOYAmt020534
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherExpensesGrp/Desc0VIRTUAL RESPOSITORY
IRS990/OtherExpensesGrp/Desc1MEMBERSHIP DUES
IRS990/OtherExpensesGrp/Desc2REGISTRATION FEES
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt0500
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt1472
IRS990/OtherExpensesGrp/ProgramServicesAmt047761
IRS990/OtherExpensesGrp/TotalAmt047761
IRS990/OtherExpensesGrp/TotalAmt1500
IRS990/OtherExpensesGrp/TotalAmt2472
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt04974
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt029478
IRS990/PrincipalOfficerNm0ANTHONY T HENDRICKSON
IRS990/ProfessionalFundraisingInd00
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt0375277
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt00
IRS990/PYInvestmentIncomeAmt00
IRS990/PYOtherExpensesAmt091055
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0284222
IRS990/PYSalariesCompEmpBnftPaidAmt00
IRS990/PYTotalExpensesAmt091055
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt0375277
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt010991
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd01
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/RelatedOrganizationsAmt020534
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd00
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/Contribution35ControlledInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ContributionControllerInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ContributionFamilyInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ControlledDisqualifiedPrsnInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/DisqualifiedPrsnControllIntInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/DisqualifiedPrsnOwnrIntInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ExcessBusinessHoldingsRulesInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/ListedByNameGoverningDocInd01
IRS990ScheduleA/Form990SchASupportingOrgGrp/LoanDisqualifiedPersonInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/OrganizationChangeSuprtOrgInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/PaymentSubstantialContribtrInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportedOrgNotOrganizedUSInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportedOrgSectionC456Ind00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportNonSupportedOrgInd00
IRS990ScheduleA/Form990SchASupportingOrgGrp/SuprtOrgNoIRSDeterminationInd00
IRS990ScheduleA/Form990SchAType1SuprtOrgGrp/OperateBenefitNonSuprtOrgInd00
IRS990ScheduleA/Form990SchAType1SuprtOrgGrp/PowerAppointMajorityDirTrstInd01
IRS990ScheduleA/OtherSupportSumAmt00
IRS990ScheduleA/SupportedOrganizationsCnt01
IRS990ScheduleA/SupportedOrganizationsTotalCnt01
IRS990ScheduleA/SupportedOrgInformationGrp/EIN0760514428
IRS990ScheduleA/SupportedOrgInformationGrp/GoverningDocumentListedInd01
IRS990ScheduleA/SupportedOrgInformationGrp/OrganizationTypeCd07
IRS990ScheduleA/SupportedOrgInformationGrp/OtherSupportAmt00
IRS990ScheduleA/SupportedOrgInformationGrp/SupportAmt00
IRS990ScheduleA/SupportedOrgInformationGrp/SupportedOrganizationName/BusinessNameLine1Txt0MELANOMA RESEARCH FOUNDATION
IRS990ScheduleA/SupportingOrganization509a3Ind0X
IRS990ScheduleA/SupportingOrgType1Ind0X
IRS990ScheduleA/SupportSumAmt00
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/FootnoteTextInd0X
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt0THE CONSORTIUM PERFORMED AN EVALUATION OF UNCERTAINTY IN INCOME TAXES FOR THE YEAR ENDED MARCH 31, 2020, AND DETERMINED THAT THERE WERE NO MATTERS THAT WOULD REQUIRE RECOGNITION IN THE FINANCIAL STATEMENTS OR THAT MAY HAVE ANY EFFECT ON ITS TAX-EXEMPT STATUS.
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc0PART X, LINE 2:
IRS990ScheduleD/TotalBookValueLandBuildingsAmt00
IRS990ScheduleI/GrantRecordsMaintainedInd01
IRS990ScheduleI/RecipientTable/CashGrantAmt0300000
IRS990ScheduleI/RecipientTable/IRCSectionDesc0501(C)(3)
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt0RESEARCH
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt0UNIVERSITY OF PITTSBURGH
IRS990ScheduleI/RecipientTable/RecipientEIN0250965591
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt0500 ROSS STREET SUITE 154-0455
IRS990ScheduleI/RecipientTable/USAddress/CityNm0PITTSBURGH
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd0PA
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd0152620001
IRS990ScheduleI/SupplementalInformationDetail/ExplanationTxt0THE CONSORTIUM'S GRANT IS CONDUCTED IN A FAIR AND OPEN PROCESS, WITH STATED ELIGIBILITY CRITERIA THAT CONTROL COI AND IMPACT AND FEASIBILITY OF THE PROPOSED RESEARCH. IT IS REVIEWED BY A PEER REVIEWED COMMITTEE THAT IS CONTROLLED FOR COI, WITH GRANTS RANKED AND SCORED. THE GRANT ADMINISTRATION OF THE CONSORTIUM MONITORS THE PROGRESS, RESULTS AND FINANCES THROUGH PROGRESS REPORTS AND SURVEYS OF ROI. AWARDEES WILL BE EXPECTED TO PROVIDE STATUS UPDATES AT THE CONSORTIUM'S BI-ANNUAL MEETINGS. IN ADDITION, INTERIM FINANCIAL AND SCIENTIFIC PROGRESS REPORTS ARE TO BE SUBMITTED TO THE MRF NO LATER THAN 30 DAYS PRIOR TO THE END OF YEAR ONE. FINAL FINANCIAL AND SCIENTIFIC REPORTS, DETAILING ALL ACTIVITIES DURING THE AWARD PERIOD ARE TO BE SUBMITTED TO THE MRF WITHIN 60 DAYS OF THE END OF THE AWARD PERIOD. THE REPORT FORM REQUESTS SUMMARIES AND OUTCOMES ON THE RESEARCH, PRESENTATIONS, PUBLICATIONS, PATENTS, CLINICAL TRIALS, NEW COLLABORATIONS, AND/OR NEW RESEARCH FUNDING PURSUANT TO THE PROPOSED RESEARCH. ACKNOWLEDGMENT OF SUPPORT FROM THE MRF & BMS MUST ACCOMPANY ANY PUBLISHED REPORT USING DATA OR FINDINGS FROM RESEARCH CONDUCTED UNDER THIS AWARD.
IRS990ScheduleI/SupplementalInformationDetail/FormAndLineReferenceDesc0PART I, LINE 2:
IRS990ScheduleI/Total501c3OrgCnt01
IRS990ScheduleI/TotalOtherOrgCnt00
IRS990/ScheduleJRequiredInd00
IRS990/ScheduleORequiredInd01
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0THE CONSORTIUM HAS ONE CLASS OF MEMBERS. THE QUALIFICATIONS AND ELIGIBILITY FOR MEMBERSHIP AND THE MANNER OF ADMISSION INTO MEMBERSHIP SHALL BE PRESCRIBED BY RESOLUTION OF THE BOARD OF DIRECTORS AND/OR BY ANY SIMILARLY PRESCRIBED RULES AND REGULATIONS WHICH THE BOARD OF DIRECTORS MAY PROMULGATE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1EACH MEMBERSHIP SHALL ENTITLE THE HOLDER THEREOF TO ONE VOTE IN ALL MATTERS WHICH ARE REQUIRED OR PERMITTED TO BE SUBMITTED TO THE MEMBERSHIP, INCLUDING THE ELECTION OR APPOINTMENT OF THE BOARD OF DIRECTORS OF THE CONSORTIUM.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2EACH MEMBERSHIP SHALL ENTITLE THE HOLDER THEREOF TO ONE VOTE IN ALL MATTERS WHICH ARE REQUIRED OR PERMITTED TO BE SUBMITTED TO THE MEMBERSHIP, INCLUDING THE ELECTION OR APPOINTMENT OF THE BOARD OF DIRECTORS OF THE CONSORTIUM.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3THE CONSORTIUM HIRES AN INDEPENDENT ACCOUNTING FIRM TO PREPARE THE FEDERAL FORM 990. UPON SUBMISSION OF THE FINAL DRAFT 990, THE BOARD OF DIRECTORS REVIEWS AND APPROVES PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4FULL DISCLOSURE, BY NOTICE IN WRITING, SHALL BE MADE BY THE INTERESTED PARTIES TO THE FULL BOARD OF DIRECTORS WITH RESPECT TO ALL CONFLICTS OF INTEREST. FOLLOWING FULL DISCLOSURE OF A POTENTIAL CONFLICT, THE BOARD OF DIRECTORS WILL DETERMINE IF A CONFLICT EXISTS. SHOULD A CONFLICT EXIST, THAT INTERESTED PERSON WILL NOT PARTICIPATE IN ANY DISCUSSION OR VOTE ON THE MATTER.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5THE GOVERNING DOCUMENTS, CONFLICTS OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990, PART VI, SECTION A, LINE 6
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PART VI, SECTION A, LINE 7A
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PART VI, SECTION A, LINE 7B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PART VI, SECTION B, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PART VI, SECTION B, LINE 12C
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5FORM 990, PART VI, SECTION C, LINE 19
IRS990ScheduleR/AssetExchangeInd00
IRS990ScheduleR/AssetPurchaseFromOtherOrgInd00
IRS990ScheduleR/AssetSaleToOtherOrgInd00
IRS990ScheduleR/DivRelatedOrganizationInd00
IRS990ScheduleR/GiftGrntCapContriFromOthOrgInd01
IRS990ScheduleR/GiftGrntOrCapContriToOthOrgInd00
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/ControlledOrganizationInd00
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/DirectControllingNACd0N/A
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/DisregardedEntityName/BusinessNameLine1Txt0MELANOMA RESEARCH FOUNDATION
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/EIN0760514428
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/ExemptCodeSectionTxt0501(C)(3)
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/LegalDomicileStateCd0TX
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/PrimaryActivitiesTxt0RESEARCH, AWARENESS AND ADVOCACY FOR MELANOMA
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/PublicCharityStatusTxt0LINE 7
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/USAddress/AddressLine1Txt01411 K STREET NW SUITE 800
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/USAddress/CityNm0WASHINGTON
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/USAddress/StateAbbreviationCd0DC
IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/USAddress/ZIPCd020005
IRS990ScheduleR/LoansOrGuaranteesFromOthOrgInd00
IRS990ScheduleR/LoansOrGuaranteesToOtherOrgInd00
IRS990ScheduleR/PaidEmployeesSharingInd00
IRS990ScheduleR/PerformOfServicesByOtherOrgInd00
IRS990ScheduleR/PerformOfServicesForOthOrgInd00
IRS990ScheduleR/ReceiptOfIntAnntsRntsRyltsInd00
IRS990ScheduleR/ReimbursementPaidByOtherOrgInd00
IRS990ScheduleR/ReimbursementPaidToOtherOrgInd00
IRS990ScheduleR/RentalOfFacilitiesToOthOrgInd00
IRS990ScheduleR/RentalOfFcltsFromOthOrgInd00
IRS990ScheduleR/SharingOfFacilitiesInd01
IRS990ScheduleR/TransferFromOtherOrgInd00
IRS990ScheduleR/TransferToOtherOrgInd00
IRS990/SchoolOperatingInd00
IRS990/SignificantChangeInd00
IRS990/SignificantNewProgramSrvcInd00
IRS990/SubjectToExcsTaxNetInvstIncInd00
IRS990/SubjectToProxyTaxInd00
IRS990/SubjToTaxRmnrtnExPrchtPymtInd00
IRS990/TaxablePartyNotificationInd00
IRS990/TaxExemptBondsInd00
IRS990/TerminateOperationsInd00
IRS990/TotalAssetsBOYAmt0603844
IRS990/TotalAssetsEOYAmt0558333
IRS990/TotalAssetsGrp/BOYAmt0603844
IRS990/TotalAssetsGrp/EOYAmt0558333
IRS990/TotalCompGreaterThan150KInd00
IRS990/TotalContributionsAmt0390534
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt013538
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0366005
IRS990/TotalFunctionalExpensesGrp/TotalAmt0379543
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt0140085
IRS990/TotalLiabilitiesEOYAmt083583
IRS990/TotalLiabilitiesGrp/BOYAmt0140085
IRS990/TotalLiabilitiesGrp/EOYAmt083583
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt0463759
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt0474750
IRS990/TotalOtherCompensationAmt00
IRS990/TotalProgramServiceExpensesAmt0366005
IRS990/TotalReportableCompFromOrgAmt00
IRS990/TotalRevenueGrp/ExclusionAmt00
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt00
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt0390534
IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt00
IRS990/TotalVolunteersCnt09
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt0603844
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt0558333
IRS990/TotReportableCompRltdOrgAmt00
IRS990/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd00
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt01420 K STREET NW 7TH FLOOR
IRS990/USAddress/CityNm0WASHINGTON
IRS990/USAddress/StateAbbreviationCd0DC
IRS990/USAddress/ZIPCd020005
IRS990/VotingMembersGoverningBodyCnt07
IRS990/VotingMembersIndependentCnt07
IRS990/WebsiteAddressTxt0WWW.MELANOMA.ORG/RESEARCH/MRF-BREAKTHROUGH-CONSOR
IRS990/WhistleblowerPolicyInd01
ReturnHeader/BuildTS02021-01-29 14:40:06Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0ANTHONY T HENDRICKSON
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0TREASURER & CFO
ReturnHeader/BusinessOfficerGrp/PhoneNum02023479675
ReturnHeader/BusinessOfficerGrp/SignatureDt02020-10-16
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0MELANOMA RESEARCH FOUNDATION
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0BREAKTHROUGH CONSORTIUM INC
ReturnHeader/Filer/BusinessNameControlTxt0MELA
ReturnHeader/Filer/EIN0800671049
ReturnHeader/Filer/PhoneNum02023479675

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2020 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$558,333
Liabilities
$83,583
Net assets
$474,750
Revenue
$390,534
Expenses
$379,543
Net income
$10,991
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2021Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.00$0.00$0.00$0.32$0.31$0.01
2020Detailed filing. Detailed filing data is available for this year.$0.56$0.08$0.47$0.39$0.38$0.01
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.60$0.14$0.46$0.38$0.09$0.28
2018XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.59$0.41$0.18$0.54$0.60$0.06
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.31$0.07$0.24$0.22$0.24$0.02
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.99$0.73$0.25$0.71$0.54$0.17
2015Summary only. Only limited summary data is available for this year.$1.25$1.20$0.05$0.14$0.16$0.03
2014Summary only. Only limited summary data is available for this year.$1.19$1.13$0.06$0.85$0.96$0.10